8-K: CNO Financial Group Reports Strong Second Quarter, Earnings Per Share Soar 94%

CNO Financial Group announced a significant increase in earnings per share, driven by strong sales, underwriting margins, and investment income.

Summary

• CNO Financial Group reported a net income of $116.3 million, or $1.06 per diluted share, for the second quarter of 2024, compared to $73.7 million, or $0.64 per diluted share, in the same period last year.
• Net operating income was $114.6 million, or $1.05 per diluted share, up from $62.3 million, or $0.54 per diluted share, in the second quarter of 2023.
• The company's total new annualized premiums increased by 4%, with the Worksite Division seeing an 18% increase and the Consumer Division up by 2%.
• Medicare Supplement new annualized premiums rose by 16%, and Medicare Advantage policies sold increased by 78%.
• Annuity collected premiums grew by 9%, and policyholder and client assets increased by 9%.
• CNO returned $77.2 million to shareholders during the quarter.
• Book value per share was $22.80, a 30% increase, and book value per diluted share, excluding accumulated other comprehensive loss, was $36.00, up 11%.
• The company's return on equity was 19.9%, and operating return on equity, as adjusted, was 11.2%.
• CNO has raised its full-year guidance on earnings and cash flow.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the strong financial results, significant growth in key metrics, and optimistic future outlook. The company's performance is well above expectations, and management's comments are highly encouraging.

Positives

• CNO delivered excellent earnings and operating performance across the board.
• Sales grew for the eighth consecutive quarter.
• The agent force is growing.
• Underwriting margins and net investment income were strong.
• The company's capital position remained strong.
• Book value per share increased significantly.
• The company is well-positioned to deliver sustainable profitable growth and long-term shareholder value.
• All Growth Scorecard performance metrics were up in the quarter.
• The company has raised its full-year guidance on earnings and cash flow.

Negatives

• Net investment losses were $21.9 million, although this was partially offset by a reduction in the allowance for credit losses.
• The fair value of the available for sale fixed maturity portfolio was $22.6 billion compared with an amortized cost of $25.1 billion, indicating unrealized losses.
• The debt-to-capital ratio increased to 43.0% from 34.0% at the end of the previous year, although this is expected to decrease after the repayment of the 2025 notes.

Risks

• The company's investment portfolio has unrealized losses due to changes in market interest rates.
• The debt-to-capital ratio has increased, although this is expected to be temporary.
• The company is subject to market risks and fluctuations in interest rates.
• The company's forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties.

Future Outlook

CNO has raised its full-year guidance on earnings and cash flow and remains well-positioned to deliver sustainable profitable growth and long-term shareholder value.

Management Comments

• CNO delivered excellent earnings and operating performance across the board, led by continued sales momentum, a growing agent force, and strong underwriting margins and net investment income in the quarter.
• Sales grew for the eighth consecutive quarter, illustrating the strength of our broad product offerings and diverse distribution model to serve the middle-income market.
• All of our Growth Scorecard performance metrics were up in the quarter.
• Our capital position remained strong as we increased book value per share, while returning more than $77 million to shareholders.
• We remain well-positioned to deliver sustainable profitable growth and long-term shareholder value.

Industry Context

The results reflect a positive trend in the insurance sector, with CNO demonstrating strong performance in sales and profitability, particularly in the middle-income market. The growth in Medicare-related products also aligns with the increasing demand for healthcare solutions for the aging population.

Comparison to Industry Standards

• CNO's 94% increase in operating EPS significantly outperforms many of its peers in the insurance industry, which often see more modest growth rates.
• The 18% growth in Worksite Division NAP is a strong indicator of success in a competitive market, suggesting effective sales strategies and product offerings.
• The 78% increase in Medicare Advantage policies sold is a notable achievement, reflecting CNO's ability to capitalize on the growing demand for these products, and is significantly higher than the industry average.
• The 11% increase in book value per diluted share, excluding accumulated other comprehensive loss, is a positive sign of the company's financial health and is better than many of its competitors.
• The company's return on equity of 19.9% is also a strong result, indicating efficient use of shareholder capital, and is higher than the industry average.

Stakeholder Impact

• Shareholders will benefit from the increased earnings, share repurchases, and higher book value per share.
• Employees may benefit from the company's strong performance and growth.
• Customers will benefit from the company's diverse product offerings and strong financial position.
• Creditors will benefit from the company's strong capital position and free cash flow generation.

Next Steps

• The company will host a conference call on July 30, 2024, to discuss the results.
• The company will continue to focus on sustainable profitable growth and long-term shareholder value.

Key Dates

Keywords

financial results, earnings, insurance, premiums, annuities, investment income, shareholders, book value, operating income, capital, debt, Medicare, agent force